DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPR
- PMID: 7950899
- DOI: 10.1097/00008469-199407000-00017
DNA flow cytometry as a surrogate end-point in patients with superficial bladder cancer treated with 4-HPR
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical